OCD1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chromadex Corp

Watchlist Manager

Watchlist

Price: 3.02 EUR -1.31% Market Closed

Market Cap: €228.1m

C	Chromadex Corp SWB:OCD1	US
	JHS Svendgaard Laboratories Ltd BSE:532771	IN
	ECS Botanics Holdings Ltd ASX:ECS	AU
	Pental Ltd F:81B	AU
	Questor Technology Inc XTSX:QST	CA

Profitability Summary

Chromadex Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

59% > 62%

Low Operating Margin

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-11% > 8%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-8% > 9%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 12%

Positive ROE

23%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-8%

ROIC is Increasing

-48% > 45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.